Literature DB >> 17272609

Guidelines for implementation of cystic fibrosis newborn screening programs: Cystic Fibrosis Foundation workshop report.

Anne Marie Comeau1, Frank J Accurso, Terry B White, Preston W Campbell, Gary Hoffman, Richard B Parad, Benjamin S Wilfond, Margaret Rosenfeld, Marci K Sontag, John Massie, Philip M Farrell, Brian P O'Sullivan.   

Abstract

Newborn screening for cystic fibrosis offers the opportunity for early intervention and improved outcomes. This summary, resulting from a workshop sponsored by the Cystic Fibrosis Foundation to facilitate implementation of widespread high quality cystic fibrosis newborn screening, outlines the steps necessary for success based on the experience of existing programs. Planning should begin with a workgroup composed of those who will be responsible for the success of the local program, typically including the state newborn screening program director and cystic fibrosis care center directors. The workgroup must develop a screening algorithm based on program resources and goals including mechanisms available for sample collection, regional demographics, the spectrum of cystic fibrosis disease to be detected, and acceptable failure rates of the screen. The workgroup must also ensure that all necessary guidelines and resources for screening, diagnosis, and care be in place prior to cystic fibrosis newborn screening implementation. These include educational materials for parents and primary care providers; systems for screening and for providing diagnostic testing and counseling for screen-positive infants and their families; and protocols for care of this unique population. This summary explores the benefits and risks of various screening algorithms, including complex situations that can occur involving unclear diagnostic results, and provides guidelines and sample materials for state newborn screening programs to develop and implement high quality screening for cystic fibrosis.

Entities:  

Mesh:

Year:  2007        PMID: 17272609     DOI: 10.1542/peds.2006-1993

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  36 in total

1.  Newborn screening for cystic fibrosis in Alberta: Two years of experience.

Authors:  Margaret Lilley; Susan Christian; Stacey Hume; Patrick Scott; Mark Montgomery; Lisa Semple; Peter Zuberbuhler; Joan Tabak; Fiona Bamforth; Martin J Somerville
Journal:  Paediatr Child Health       Date:  2010-11       Impact factor: 2.253

2.  Quality performance of newborn screening systems: strategies for improvement.

Authors:  D Webster
Journal:  J Inherit Metab Dis       Date:  2007-08-14       Impact factor: 4.982

3.  Ethical, legal, and social issues in health technology assessment for prenatal/preconceptional and newborn screening: a workshop report.

Authors:  B K Potter; D Avard; V Entwistle; C Kennedy; P Chakraborty; M McGuire; B J Wilson
Journal:  Public Health Genomics       Date:  2008-09-03       Impact factor: 2.000

4.  Opportunities for quality improvement in cystic fibrosis newborn screening.

Authors:  Molly K Groose; Richard Reynolds; Zhanhai Li; Philip M Farrell
Journal:  J Cyst Fibros       Date:  2010-05-14       Impact factor: 5.482

5.  Clinical and ethical considerations in managing carrier detection.

Authors:  Lainie Friedman Ross; Ellen Wright Clayton
Journal:  Am J Public Health       Date:  2009-06-18       Impact factor: 9.308

Review 6.  Update in cystic fibrosis 2007.

Authors:  Frank J Accurso
Journal:  Am J Respir Crit Care Med       Date:  2008-05-15       Impact factor: 21.405

7.  Parents' experience with positive newborn screening results for cystic fibrosis.

Authors:  Inken Brockow; Uta Nennstiel
Journal:  Eur J Pediatr       Date:  2019-03-09       Impact factor: 3.183

8.  Cystic fibrosis newborn screening: using experience to optimize the screening algorithm.

Authors:  Jaime E Hale; Richard B Parad; Henry L Dorkin; Robert Gerstle; Allen Lapey; Brian P O'Sullivan; Terry Spencer; William Yee; Anne Marie Comeau
Journal:  J Inherit Metab Dis       Date:  2010-06-03       Impact factor: 4.982

Review 9.  Newborn screening for cystic fibrosis.

Authors:  Jack K Sharp; Michael J Rock
Journal:  Clin Rev Allergy Immunol       Date:  2008-12       Impact factor: 8.667

Review 10.  Background and Epidemiology.

Authors:  Don B Sanders; Aliza K Fink
Journal:  Pediatr Clin North Am       Date:  2016-08       Impact factor: 3.278

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.